Rheumatoid Arthritis in Tight Disease Control is No Longer Risk of Bone Mineral Density Loss

Overview

Journal Osteoporos Sarcopenia

Date 2020 Jul 28

PMID 32715098

Citations 9

Authors

Ichiro Yoshii

Tatsumi Chijiwa

Naoya Sawada

Affiliations

Soon will be listed here.

Abstract

Objectives: Rheumatoid arthritis (RA) is an independent risk factor of osteoporosis. However, if disease activity is successfully controlled using the treat-to-target (T2T) strategy, the risk of bone mineral density (BMD) loss can be diminished. We evaluated if RA is a risk factor even when the T2T is applied in clinical cases.

Methods: From September 2017 to August 2019, 741 patients were examined using dual-energy X-ray absorptiometry; of these, 279 were diagnosed with RA who attained clinical remission within 6 months (RA-rem) and 53 could not attain clinical remission (RA-nonrem), while 409 were not diagnosed with RA (non-RA). The following characteristics between RA-rem and non-RA were matched using the propensity score matching (PSM) technique: age, sex, past bone fragility fracture experience, osteoporosis drug intervention ratio, glucocorticoid administration ratio, mean dose, Barthel Index score, body mass index, serum-creatinine-to-cystatin C ratio, and the number of comorbidities. The BMDs and changes of the lumbar spine, femoral neck, total hip, and greater trochanter were statistically compared between the RA-rem and the non-RA after PSM, and between RA-nonrem and RA-rem after PSM using the Mann-Whitney U test.

Results: In total, 107 patients of RA-rem and 108 of non-RA were recruited. BMDs and changes of every part demonstrated no significant differences between the 2 groups. BMDs in every part of RA-rem after PSM were significantly greater than those in every part of RA-nonrem, while no significant difference in change during follow-up.

Conclusions: If disease activity is controlled in clinical remission, RA will not contribute to BMD reduction.

Citing Articles

Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases.

Buttgereit F, Palmowski A, Bond M, Adami G, Dejaco C Nat Rev Rheumatol. 2024; 20(7):417-431.

PMID: 38831028 DOI: 10.1038/s41584-024-01120-w.

Rheumatoid arthritis, disease-modifying antirheumatic drugs and risk of major osteoporotic fracture: prospective data from the HUNT Study, Norway.

Tronstad I, Hoff M, Horn J, Vikjord S, Videm V, Johansson J RMD Open. 2024; 10(1).

PMID: 38382944 PMC: 10882308. DOI: 10.1136/rmdopen-2023-003919.

Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years.

Ajeganova S, Andersson M, Forslind K, Gjertsson I, Nyhall-Wahlin B, Svensson B BMC Rheumatol. 2023; 7(1):23.

PMID: 37550762 PMC: 10405460. DOI: 10.1186/s41927-023-00347-6.

Impact of Treat-to-Target Therapy on Bone Mineral Density Loss in Patients With Rheumatoid Arthritis: A Prospective Cohort Study.

Huang H, Wang Y, Xie W, Geng Y, Gao D, Zhang Z Front Endocrinol (Lausanne). 2022; 13:867610.

PMID: 35655798 PMC: 9152020. DOI: 10.3389/fendo.2022.867610.

Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort.

Wysham K, Shofer J, Lui G, Trupin L, Andrews J, Black D Semin Arthritis Rheum. 2022; 53:151972.

PMID: 35152085 PMC: 8963706. DOI: 10.1016/j.semarthrit.2022.151972.

References

Haugeberg G, Uhlig T, Falch J, Halse J, Kvien T . Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000; 43(3):522-30. DOI: 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y. View

Guler-Yuksel M, Allaart C, Goekoop-Ruiterman Y, de Vries-Bouwstra J, van Groenendael J, Mallee C . Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis. 2008; 68(3):330-6. DOI: 10.1136/ard.2007.086348. View

Omata Y, Hagiwara F, Nishino J, Matsudaira K, Kadono Y, Juji T . Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients. J Bone Miner Metab. 2013; 32(6):725-31. DOI: 10.1007/s00774-013-0552-8. View

Laan R, Buijs W, Verbeek A, Draad M, Corstens F, van de Putte L . Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis. 1993; 52(1):21-6. PMC: 1004950. DOI: 10.1136/ard.52.1.21. View

van Staa T, Geusens P, Bijlsma J, Leufkens H, Cooper C . Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006; 54(10):3104-12. DOI: 10.1002/art.22117. View

Kanis J, Johansson H, Oden A, Johnell O, De Laet C, Melton Iii L . A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004; 19(6):893-9. DOI: 10.1359/JBMR.040134. View

Cortet B, Guyot M, Solau E, Pigny P, Dumoulin F, Flipo R . Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol. 2001; 18(6):683-90. View

Cummings S, Nevitt M, Browner W, Stone K, Fox K, Ensrud K . Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332(12):767-73. DOI: 10.1056/NEJM199503233321202. View

Gomez-Vaquero C, Martin I, Loza E, Carmona L, Ivorra J, Narvaez J . Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. PLoS One. 2016; 11(12):e0166691. PMC: 5135438. DOI: 10.1371/journal.pone.0166691. View

10.

MAHONEY F, BARTHEL D . FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965; 14:61-5. View

11.

Siris E, Miller P, Barrett-Connor E, Faulkner K, Wehren L, Abbott T . Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001; 286(22):2815-22. DOI: 10.1001/jama.286.22.2815. View

12.

Dawson-Hughes B, Tosteson A, Melton 3rd L, Baim S, Favus M, Khosla S . Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008; 19(4):449-58. DOI: 10.1007/s00198-008-0559-5. View

13.

Santos-Moreno P, de la Hoz-Valle J, Villarreal L, Palomino A, Sanchez G, Castro C . Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort study. Clin Rheumatol. 2014; 34(2):215-20. DOI: 10.1007/s10067-014-2794-9. View

14.

Brennan S, Toomey L, Kotowicz M, Henry M, Griffiths H, Pasco J . Rheumatoid arthritis and incident fracture in women: a case-control study. BMC Musculoskelet Disord. 2014; 15:13. PMC: 3893404. DOI: 10.1186/1471-2474-15-13. View

15.

Coulson K, Reed G, Gilliam B, Kremer J, Pepmueller P . Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol. 2009; 15(4):155-60. DOI: 10.1097/RHU.0b013e3181a5679d. View

16.

Osaka T, Hamaguchi M, Hashimoto Y, Ushigome E, Tanaka M, Yamazaki M . Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes. Diabetes Res Clin Pract. 2018; 139:52-58. DOI: 10.1016/j.diabres.2018.02.025. View

17.

Ochi K, Inoue E, Furuya T, Ikari K, Toyama Y, Taniguchi A . Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture. Osteoporos Int. 2014; 26(3):961-8. DOI: 10.1007/s00198-014-2911-2. View

18.

Huusko T, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R . Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis. 2001; 60(5):521-2. PMC: 1753630. DOI: 10.1136/ard.60.5.521. View

19.

Guler H, Turhanoglu A, Ozer B, Ozer C, Balci A . The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis. Scand J Rheumatol. 2008; 37(5):337-42. DOI: 10.1080/03009740801998812. View

20.

Kim S, Schneeweiss S, Liu J, Daniel G, Chang C, Garneau K . Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther. 2010; 12(4):R154. PMC: 2945054. DOI: 10.1186/ar3107. View